LHX2 Is a Potential Biomarker and Associated with Immune Infiltration in Breast Cancer

SIMPLE SUMMARY: Breast cancer is one of the most common malignant tumors in women, and metastatic breast cancer usually has a poor prognosis. Hence, it is urgent to identify new biomarkers to promote precise medication in breast cancer. LHX2 has been reported to promote the proliferation of numerous...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ziwei, Gu, Minghao, He, Gao, Yu, Xiafei, Yang, Junzhe, Wu, Xian, Zhang, Xiaoqiang, Lu, Kaining, Qian, Fangze, Shi, Xiaoyue, Xu, Jialu, Zhuang, Minyu, Liu, Xiaoan, Zhu, Yanhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216828/
https://www.ncbi.nlm.nih.gov/pubmed/37345110
http://dx.doi.org/10.3390/cancers15102773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216828/
https://www.ncbi.nlm.nih.gov/pubmed/37345110
http://dx.doi.org/10.3390/cancers15102773

Ejemplares similares